Introduction
CACNA1A (Calcium Voltage-Gated Channel Subunit Alpha1 A) encodes the alpha-1A subunit of voltage-gated P/Q-type calcium channels (CaV2.1), one of the most important voltage-gated calcium channels in the central nervous system. These channels are critical for neurotransmitter release at presynaptic terminals, particularly in cerebellar Purkinje cells and hippocampal neurons. Mutations in CACNA1A cause a spectrum of neurological disorders including spinocerebellar ataxias, familial hemiplegic migraine, episodic ataxia, and epilepsy 1"CaV2.1 channelopathies." *Pflugers Archiv : European journal of physiology* (2010)Open reference.
| CACNA1A Gene Information | |
|---|---|
| Symbol | CACNA1A |
| Full Name | Calcium Voltage-Gated Channel Subunit Alpha1 A |
| Chromosomal Location | 19p13.2 |
| NCBI Gene ID | [773](https://www.ncbi.nlm.nih.gov/gene/773) |
| OMIM | [601011](https://www.omim.org/entry/601011) |
| Ensembl ID | [ENSG00000141837](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000141837) |
| UniProt | [O00555](https://www.uniprot.org/uniprot/O00555) |
| Protein | [CaV2.1 (P/Q-type calcium channel)](/proteins/cav2.1-) |
| Associated Diseases | [SCA2](/diseases/spinocerebellar-ataxia-type-2), [FHM](/diseases/familial-hemiplegic-migraine), [Epilepsy](/diseases/epilepsy), [Developmental Ataxia](/diseases/developmental-ataxia) |
Overview
The CACNA1A gene is essential for normal neurological function. It encodes the pore-forming alpha-1A subunit of P/Q-type calcium channels, which are high-voltage-activated channels that conduct calcium ions essential for synaptic transmission. The channel consists of multiple subunits:
-
Alpha-1A subunit: The pore-forming subunit encoded by CACNA1A
-
Alpha-2/delta subunit: Auxiliary subunit that modulates channel trafficking and function
-
Beta subunit: Auxiliary subunit that regulates channel kinetics
-
Gamma subunit: Auxiliary subunit that influences channel properties
P/Q-type channels are the predominant calcium channel type at cerebellar synapses, where they mediate fast synaptic transmission and are critical for proper motor coordination 2"The episodic ataxias." *Handbook of clinical neurology* (2024)Open reference.
Function
Normal Physiological Function
CACNA1A-encoded CaV2.1 channels play several critical roles in the nervous system:
-
Synaptic Transmission: P/Q-type channels are the primary voltage-gated calcium channels at presynaptic terminals, triggering neurotransmitter release through their high-affinity calcium binding 3"P-type calcium channels in rat central and peripheral neurons." *Neuron* (1992)Open reference.
-
Cerebellar Function: CaV2.1 channels are essential for proper cerebellar Purkinje cell function, which integrates motor learning signals and coordinates movement.
-
Hippocampal Signaling: In the hippocampus, P/Q-type channels contribute to synaptic plasticity, learning, and memory processes.
-
Neuromuscular Junction: At the motor nerve terminal, P/Q-type channels mediate acetylcholine release for muscle contraction.
-
Gene Regulation: Through calcium-dependent signaling cascades, these channels regulate transcription factors and gene expression programs important for neuronal survival.
Channel Structure and Gating
The CaV2.1 channel has complex gating properties:
-
Activation: Voltage-dependent opening at membrane potentials around -40 mV
-
Inactivation: Both voltage-dependent and calcium-dependent inactivation
-
Conductance: High single-channel conductance (~15 pS)
-
Dihydropyridine sensitivity: Differs from L-type channels
Expression Pattern
CaV2.1 channels are expressed in a cell-type specific manner:
| Brain Region | Expression Level | Primary Cell Types |
|---|---|---|
| Cerebellum | Very High | Purkinje cells, Granule cells |
| Hippocampus | High | CA3 pyramidal cells, Interneurons |
| Cerebral Cortex | High | Layer 5 pyramidal neurons |
| Thalamus | High | Relay neurons |
| Dorsal Root Ganglia | Moderate | Sensory neurons |
| Brainstem | Moderate | Various neuron types |
The high expression in cerebellar Purkinje cells explains the ataxia phenotypes observed in CACNA1A mutations 4"Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias." *American journal of human genetics* (2023)Open reference.
Role in Neurodegenerative Diseases
Alzheimer’s Disease
Emerging evidence links CACNA1A to Alzheimer’s disease pathogenesis:
-
Calcium Dysregulation: AD brains show altered P/Q-type channel expression and function, contributing to the calcium dysregulation hypothesis of AD 5"Calcium channel dysfunction in the entorhinal cortex in Alzheimer disease." *Neurobiology of Aging* (2015)Open reference.
-
Synaptic Loss: CaV2.1 dysfunction contributes to impaired synaptic transmission in AD.
-
Excitotoxicity: Dysregulated calcium influx through mutant channels may contribute to excitotoxic neuronal death.
-
Amyloid Interaction: Amyloid-beta oligomers can directly affect P/Q-type channel function in hippocampal neurons 6"P/Q-type calcium channel dysfunction in primary cortical neurons from the 5xFAD mouse model of Alzheimer disease." *Acta Neuropathologica Communications* (2020)Open reference.
| AD Association | Mechanism |
|---|---|
| Calcium dysregulation | Altered channel expression/function |
| Synaptic impairment | Reduced neurotransmitter release |
| Excitotoxicity | Abnormal calcium influx |
| Memory deficits | Hippocampal dysfunction |
Parkinson’s Disease
While less studied than in AD, CACNA1A may play roles in PD:
-
Nigral Expression: P/Q-type channels are expressed in dopaminergic neurons of the substantia nigra.
-
Calcium-dependent Vulnerability: The unique calcium dynamics of dopaminergic neurons may be affected by CACNA1A variants.
-
Therapeutic Implications: P/Q-type channel modulators are being explored as potential neuroprotective agents.
Spinocerebellar Ataxia Type 2 (SCA2)
CACNA1A mutations cause SCA2, one of the most common autosomal dominant ataxias:
-
Pathogenic Mechanisms: Polyglutamine expansions and point mutations lead to channel dysfunction.
-
Phenotype: Progressive ataxia, dysarthria, peripheral neuropathy, and slow saccades.
-
Therapeutic Approaches: Gene therapy and small molecule correctors under investigation.
Other Neurological Disorders
| Disorder | CACNA1A Role |
|---|---|
| Familial Hemiplegic Migraine (FHM) | Gain-of-function mutations cause aura and hemiparesis |
| Episodic Ataxia Type 2 (EA2) | Loss-of-function mutations cause episodic ataxia and nystagmus |
| Epilepsy | Various mutations cause neuronal hyperexcitability |
| Developmental Ataxia | Developmental delays with ataxic features |
Molecular Mechanisms
Calcium-Dependent Signaling
flowchart TD
A["CaV2.1 Channel Opening"] --> B["Ca2+ Influx"]
B --> C["Calmodulin Activation"]
C --> D["CaMKII Activation"]
D --> E["CREB Phosphorylation"]
E --> F["Gene Transcription"]
F --> G["Synaptic Plasticity"]
B --> H["Neurotransmitter Release"]
H --> I["Synaptic Transmission"]
J["Dysregulation"] --> K["Excitotoxicity"]
J --> L["Oxidative Stress"]
K --> M["Neuronal Death"]
L --> M
style A fill:#99ff99
style J fill:#3a3000999
style M fill:#ff0000Channel Dysfunction Mechanisms
-
Loss-of-function: Reduced channel activity leads to decreased neurotransmitter release
-
Gain-of-function: Increased channel activity causes calcium overload and excitotoxicity
-
Dominant-negative: Mutant subunits incorporate into channels and impair function
-
Trafficking defects: Mutations affect channel localization to the membrane
Therapeutic Approaches
Current Treatments
-
Acetazolamide: Carbonic anhydrase inhibitor used for episodic ataxia
-
Flunarizine: Calcium channel blocker for migraine prophylaxis
-
Topiramate: Anti-convulsant with calcium channel effects
-
Valproic Acid: Mood stabilizer with calcium channel modulatory effects
Emerging Therapies
| Approach | Status | Target |
|---|---|---|
| Gene therapy | Preclinical | Restore channel function |
| Small molecule correctors | Discovery | Improve channel trafficking |
| Antisense oligonucleotides | Research | Reduce toxic protein expression |
| Calcium channel blockers | Clinical trials | Reduce excitotoxicity |
Genetics and Inheritance
Mutation Types
-
Missense mutations: Alter channel gating or conductance
-
Nonsense/frameshift: Cause haploinsufficiency
-
SCA2 expansions: CAG repeat expansions causing polyglutamine toxicity
-
Splice site mutations: Altered channel isoform expression
Inheritance Patterns
-
Autosomal dominant: Most SCA2, FHM, and EA2 mutations
-
De novo: Many developmental ataxia cases
-
Variable penetrance: Phenotype depends on specific mutation
Key Historical Discoveries
-
1991: First cloning of CACNA1A cDNA 7"Primary structure and functional expression from complementary DNA of the brain calcium channel." *Nature* (1991)Open reference
-
1996: Identification of FHM and EA2 mutations 8"Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4." *Cell* (1996)Open reference
-
2000s: Link to SCA2 pathogenesis established
-
2010s: CaV2.1 channel structure resolved
-
2020s: Gene therapy approaches enter development 9"CACNA1A haploinsufficiency leads to reduced synaptic function and increased intrinsic excitability." *Brain : a journal of neurology* (2025)Open reference
Animal Models
-
Tottering mouse: Natural CACNA1A mutant with ataxia and seizures
-
Rolling mouse: Another natural mutant with Purkinje cell degeneration
-
Knockout mice: Complete loss of CaV2.1 function
-
Transgenic models: Expressing human mutations for therapeutic testing
See Also
References
- "CaV2.1 channelopathies." *Pflugers Archiv : European journal of physiology* (2010)
- "The episodic ataxias." *Handbook of clinical neurology* (2024)
- "P-type calcium channels in rat central and peripheral neurons." *Neuron* (1992)
- "Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias." *American journal of human genetics* (2023)
- "Calcium channel dysfunction in the entorhinal cortex in Alzheimer disease." *Neurobiology of Aging* (2015)
- "P/Q-type calcium channel dysfunction in primary cortical neurons from the 5xFAD mouse model of Alzheimer disease." *Acta Neuropathologica Communications* (2020)
- "Primary structure and functional expression from complementary DNA of the brain calcium channel." *Nature* (1991)
- "Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4." *Cell* (1996)
- "CACNA1A haploinsufficiency leads to reduced synaptic function and increased intrinsic excitability." *Brain : a journal of neurology* (2025)
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.